Erratum: Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: Long-term follow-up results of radiation therapy oncology group 0132 (Annals of Surgical Oncology (2011) DOI: 10.1245/S10434-011-2190-5)

Dian Wang, Qiang Zhang, Charles D. Blanke, George D. Demetri, Michael C. Heinrich, James C. Watson, John P. Hoffman, Scott Okuno, John M. Kane, Margaret Von Mehren, Burton L. Eisenberg

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish (US)
    Pages (from-to)2420
    Number of pages1
    JournalAnnals of surgical oncology
    Issue number7
    StatePublished - Jul 2012

    ASJC Scopus subject areas

    • Surgery
    • Oncology

    Cite this